Chapter
Future of Infectious Disease & Trump's Treatment
08:36 - 16:38 (08:02)
The future of infectious disease may involve getting a polyclonal cocktail of antibodies every year instead of a flu shot, according to the speaker. They also speculate on the potential decision-making power of powerful individuals, such as the president, when it comes to their own medical treatment.
Clips
The future of infectious disease is in synthetic polyclonal antibody cocktails that protect against new diseases, rather than going after the leaders of the world for every illness that arises.
08:36 - 12:54 (04:18)
Summary
The future of infectious disease is in synthetic polyclonal antibody cocktails that protect against new diseases, rather than going after the leaders of the world for every illness that arises.
ChapterFuture of Infectious Disease & Trump's Treatment
EpisodeE9: Trump has COVID, First debate reactions, Coinbase letter response & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
Scaling up Regeneron's antibody treatment is not an easy task, as it requires clinical trials to determine the right way to treat and protect people from anaphylactic shock caused by an allergic reaction to the foreign antibody.
12:54 - 13:45 (00:50)
Summary
Scaling up Regeneron's antibody treatment is not an easy task, as it requires clinical trials to determine the right way to treat and protect people from anaphylactic shock caused by an allergic reaction to the foreign antibody. The trials have been ongoing since March, and Regeneron likely administered Benadryl and a steroid shot to Trump when he received the treatment.
ChapterFuture of Infectious Disease & Trump's Treatment
EpisodeE9: Trump has COVID, First debate reactions, Coinbase letter response & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The podcast discusses the possibility of President Trump receiving convalescent plasma treatment and the potential danger of him having too much control over his treatment decisions.
13:45 - 16:38 (02:53)
Summary
The podcast discusses the possibility of President Trump receiving convalescent plasma treatment and the potential danger of him having too much control over his treatment decisions. The suggested treatment involves isolating antibodies from the blood of recovered COVID patients and injecting them into the patient's body.